{"url":"https://lda.senate.gov/api/v1/filings/0daccdb2-e9b7-4fa3-a648-d27ef7287d7d/","filing_uuid":"0daccdb2-e9b7-4fa3-a648-d27ef7287d7d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2022,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/0daccdb2-e9b7-4fa3-a648-d27ef7287d7d/print/","filing_document_content_type":"text/html","income":null,"expenses":"1960000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jason D. Kaune, Attorney & Agent for Filer","dt_posted":"2022-04-20T19:34:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5200 ILLUMINA WAY","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"SAN DIEGO","registrant_state":"CA","registrant_zip":"92122","registrant":{"id":401104825,"url":"https://lda.senate.gov/api/v1/registrants/401104825/","house_registrant_id":null,"name":"ILLUMINA, INC.","description":"​Sequencing and Array-based Solutions for Genetic Research, Clinical and Applied Markets.","address_1":"5200 ILLUMINA WAY","address_2":null,"address_3":null,"address_4":null,"city":"SAN DIEGO","state":"CA","state_display":"California","zip":"92122","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JASON KAUNE","contact_telephone":"+1 415-389-6800","dt_updated":"2026-01-30T19:24:24.404436-05:00"},"client":{"id":202795,"url":"https://lda.senate.gov/api/v1/clients/202795/","client_id":12,"name":"ILLUMINA, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 6000: Cures 2.0 Act; all provisions S. 2022: Ending the Diagnostic Odyssey Act of 2021; all provisions S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics (PREVENT Pandemics) Act; all provisions General discussions related to genomics, sequencing and applications for sequencing technologies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139620,"prefix":"mr","prefix_display":"MR.","first_name":"BRIAN","nickname":null,"middle_name":"CHRISTOPHER","last_name":"TOOHEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"General discussions related to competition, access, and regulatory actions regarding Multi-Cancer Early Detection technology","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139620,"prefix":"mr","prefix_display":"MR.","first_name":"BRIAN","nickname":null,"middle_name":"CHRISTOPHER","last_name":"TOOHEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}